Fariba Assadi-Porter
CEO / Founder

This company develops breath-based diagnostic tools that analyze exhaled carbon dioxide to detect isotopic biomarkers of severe infections. Their non-invasive technology enables pre-symptomatic detection of disease, allowing for earlier medical intervention.
Raised to date
$2.6MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

CEO / Founder
Bacterial and viral infections in cattle often go undetected until visible symptoms appear, leading to delayed treatment, increased morbidity and mortality, and significant economic losses for producers. Current diagnostic methods can be slow, invasive, and require laboratory analysis, hindering timely intervention and effective disease management.
Isomark provides a rapid, non-invasive breath analysis platform for early detection of bacterial and viral infections in cattle. The Canary-AG™ device collects breath samples and uses AI-powered analysis of exhaled biomarkers to identify animals at risk of infection up to 48 hours before symptoms manifest. Results are displayed in 30 seconds via a user-friendly interface, enabling real-time, data-driven treatment decisions. The system integrates with animal electronic ID tags and management software for automated health tracking and long-term performance monitoring.
The primary target audience includes cattle producers, feedlot operators, and veterinary professionals seeking to improve animal health, reduce treatment costs, and enhance productivity through early disease detection.